Diagnosing DRESS is challenging. Some clinicians reject this diagnosis when the delay of onset is less than 15 days after drug intake.
Continue Reading→There are no specific recommendations for FDG-PET/CT in assessing recurrent cutaneous squamous cell carcinoma (cSCC).
Continue Reading→